54 related articles for article (PubMed ID: 29893312)
1. Correlation of proliferative index with various clinicopathologic prognostic parameters in primary breast carcinoma: A study from North India.
Marwah N; Batra A; Marwah S; Gupta V; Shakya S; Sen R
J Cancer Res Ther; 2018; 14(3):537-542. PubMed ID: 29893312
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of Ki67 in Chinese women diagnosed with ER
Hu Y; Gu R; Zhao J; Yang Y; Liu F; Jin L; Chen K; Jia H; Wang H; Liu Q; Su F; Jia W
BMC Cancer; 2017 Jan; 17(1):28. PubMed ID: 28061893
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of substance P in breast cancer and its association with prognostic parameters and Ki-67 index.
Al-Keilani MS; Elstaty RI; Alqudah MA; Alkhateeb AM
PLoS One; 2021; 16(6):e0252616. PubMed ID: 34086748
[TBL] [Abstract][Full Text] [Related]
4. Association between pathological characteristics and recurrence score by OncotypeDX in resected T1-3 and N0-1 breast cancer: a real-life experience of a North Hungarian regional center.
Deme D; Tamaskovics BF; Jammoul N; Kovács S; Kayode EO; Grice JW; Telekes A
Pathol Oncol Res; 2024; 30():1611735. PubMed ID: 38689824
[No Abstract] [Full Text] [Related]
5. Correlation between HER2 Expression and Clinicopathological Features of Breast Cancer: A Cross- Sectional Study in Vietnam.
Dang Cong T; Nguyen Thanh T; Nguyen Phan QA; Hoang Thi AP; Nguyen Tran BS; Nguyen Vu QH
Asian Pac J Cancer Prev; 2020 Apr; 21(4):1135-1142. PubMed ID: 32334482
[TBL] [Abstract][Full Text] [Related]
6. Correlation of microvessel density with histopathological parameters of carcinoma breast.
Goyal AV; Shukla S; Acharya S; Vagha S; Jajoo S
Indian J Med Res; 2023 Oct; 158(4):417-422. PubMed ID: 38006344
[TBL] [Abstract][Full Text] [Related]
7. Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early-stage luminal breast cancer.
van Steenhoven JEC; Kuijer A; Kornegoor R; van Leeuwen G; van Gorp J; van Dalen T; van Diest PJ
Histopathology; 2020 Oct; 77(4):579-587. PubMed ID: 32557844
[TBL] [Abstract][Full Text] [Related]
8. Respective prognostic value of genomic grade and histological proliferation markers in early stage (pN0) breast carcinoma.
Reyal F; Bollet MA; Caly M; Gentien D; Carpentier S; Peyro-Saint-Paul H; Pierga JY; Cottu P; Dieras V; Sigal-Zafrani B; Vincent-Salomon A; Sastre-Garau X
PLoS One; 2012; 7(4):e35184. PubMed ID: 22529987
[TBL] [Abstract][Full Text] [Related]
9. Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts.
Lundberg A; Lindström LS; Harrell JC; Falato C; Carlson JW; Wright PK; Foukakis T; Perou CM; Czene K; Bergh J; Tobin NP
Clin Cancer Res; 2017 Dec; 23(24):7512-7520. PubMed ID: 28972043
[No Abstract] [Full Text] [Related]
10. [Comparative immunohistochemistry study of different antibodies clones for detection of breast cancer markers (estrogen receptor, progesterone receptor, HER2/neu, Ki-67)].
Kalinin DV; Samoylova DV; Danilova NV; Germanovich NY; Kuznetsova OA; Zavalishina LE
Arkh Patol; 2024; 86(2):14-20. PubMed ID: 38591902
[TBL] [Abstract][Full Text] [Related]
11. Effects of clinicopathological factors on prognosis of young patients with resected breast cancer.
Li W; Deng Y; Wu Q; Chen W; Liu Z; Wang T; Ai C; Chen F; Wang Z; Ma G; Zhou Q
Medicine (Baltimore); 2021 Feb; 100(5):e23693. PubMed ID: 33592828
[TBL] [Abstract][Full Text] [Related]
12. Ki-67 Proliferation Index Is Associated With Tumor Grade and Survival in Pleural Epithelioid Mesotheliomas.
Galeano B; Smith CJ; Yi ES; Roden AC; Jenkins S; Capelle J; Kittle-Francis M; Mansfield AS; Aubry MC
Am J Surg Pathol; 2024 May; 48(5):615-622. PubMed ID: 38369761
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Substance P/Neurokinin 1 Receptor and Its Association with Hormonal Receptors in Breast Carcinoma.
Mehboob R; Gilani SA; Hassan A; Sadaf ; Tanvir I; Javaid S; Khalid S; Hasan S; Waseem H; Alwazzan A; Munoz M
Biomed Res Int; 2021; 2021():5577820. PubMed ID: 34692834
[TBL] [Abstract][Full Text] [Related]
14. Survival analysis in breast cancer using proteomic data from four independent datasets.
Ősz Á; Lánczky A; Győrffy B
Sci Rep; 2021 Aug; 11(1):16787. PubMed ID: 34408238
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and prognostic significance of GLUT1 in breast cancer: A meta-analysis.
Deng Y; Zou J; Deng T; Liu J
Medicine (Baltimore); 2018 Nov; 97(48):e12961. PubMed ID: 30508885
[TBL] [Abstract][Full Text] [Related]
16. Age-related phenotypes in breast cancer: A population-based study.
Svanøe AA; Humlevik ROC; Knutsvik G; Sæle AKM; Askeland C; Ingebriktsen LM; Hugaas U; Kvamme AB; Tegnander AF; Krüger K; Davidsen B; Hoivik EA; Aas T; Stefansson IM; Akslen LA; Wik E
Int J Cancer; 2024 Jun; 154(11):2014-2024. PubMed ID: 38319154
[TBL] [Abstract][Full Text] [Related]
17. Artificial Intelligence-Based Mitosis Scoring in Breast Cancer: Clinical Application.
Ibrahim A; Jahanifar M; Wahab N; Toss MS; Makhlouf S; Atallah N; Lashen AG; Katayama A; Graham S; Bilal M; Bhalerao A; Ahmed Raza SE; Snead D; Minhas F; Rajpoot N; Rakha E
Mod Pathol; 2024 Mar; 37(3):100416. PubMed ID: 38154653
[TBL] [Abstract][Full Text] [Related]
18. Subspecialized breast pathologists have suboptimal interobserver agreement in Ki-67 evaluation using 20% as the cutoff.
Ai D; Turashvili G; Gjeorgjievski SG; Wang Q; Ewaz AM; Gao Y; Nguyen T; Zhang C; Li X
Breast Cancer Res Treat; 2024 Apr; 204(2):415-422. PubMed ID: 38157098
[TBL] [Abstract][Full Text] [Related]
19. Investigating the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors.
Bahador M; Saeedi Nejad M; Dabiri S; Larizadeh MH; Soofiabadi MF
J Egypt Natl Canc Inst; 2024 Apr; 36(1):12. PubMed ID: 38616231
[TBL] [Abstract][Full Text] [Related]
20. Clinical, Histopathological, and Immunohistochemical Characteristics of Predictive Biomarkers of Breast Cancer: A Retrospective Study.
Papalexis P; Georgakopoulou VE; Keramydas D; Vogiatzis R; Taskou C; Anagnostopoulou FA; Nonni A; Lazaris AC; Zografos GC; Kavantzas N; Thomopoulou GE
Cancer Diagn Progn; 2024; 4(3):340-351. PubMed ID: 38707726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
